ACCESS Newswire
11 Sep 2019, 18:31 GMT+10
LA JOLLA, CA / ACCESSWIRE / September 11, 2019 / Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid system, announced today that it will be presenting at the 2019 Fall Investor Summit being held on September 16th-17th at the Essex House in New York City. The Fall Investor Summit will feature 160 companies and have over 1,000 institutional and retail investors in attendance.
Gregory D. Gorgas, President and Chief Executive Officer of Artelo Biosciences, is scheduled to present on Tuesday, September 17th at 10:30 a.m. Eastern Time, on Track 3, with one-on-one meetings to be held throughout the conference. The presentation will be webcast live and available for replay here.
About Artelo Biosciences
Artelo Biosciences, Inc. is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting the endocannabinoid system. Artelo is rapidly advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, pain, and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the company applies leading edge scientific, regulatory, and commercial discipline to develop high-impact therapies.
More information is available at www.artelobio.com and Twitter: @ArteloBio.
Investor Relations Contact:
Crescendo Communications, LLC
Tel: 212-671-1020
Email: [email protected]
News Compliments of ACCESSWIRE
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors.
To register as a presenting company: please contact Cassandra Miller ([email protected])
To request complimentary investor registration: please visit our website at www.microcapconf.com
FOR MORE INFORMATION
Please visit: www.microcapconf.com
Or, contact Ashley Allard at [email protected]
SOURCE: Artelo BioSciences
Get a daily dose of Boston Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Boston Star.
More InformationHONG KONG: Hong Kong's economy grew by 3.1 percent in the first quarter of this year compared to the same period last year, according...
NEW YORK, New York - U.S. stocks advanced on Wednesday while the U.S. dollar made across-the-board gains after the Federal Reserve...
LONG ISLAND CITY, New York: JetBlue Airways' plan to strike a domestic partnership with another U.S. airline is drawing sharp resistance...
LONDON, U.K.: Shell reported a better-than-expected first-quarter profit of US$5.58 billion on May 2, down 28 percent from a year earlier...
BANGKOK, Thailand: Thailand's finance ministry has revised its projection for foreign tourist arrivals this year, lowering the estimate...
NEW YORK, New York - U.S. stock markets retreated on Tuesday, with major indices posting losses amid renewed economic concerns, while...
WASHINGTON, D.C.: The U.S. Department of Defense wants to change its contracts so the Army can fix its own weapons instead of always...
WASHINGTON, D.C.: The Trump administration through U.S. Environmental Protection Agency (EPA) is canceling nearly 800 grants, including...
New Delhi [India] May 7 (ANI): Global demand for climate adaptation and resilience (A&R) solutions could reach USD 0.5 to USD 1.3 trillion...
Mumbai (Maharashtra) [India], May 3 (ANI): Union Minister of State for Information and Broadcasting and Parliamentary Affairs, L Murugan...
New Delhi [India], May 2 (ANI): India's rapidly growing creator landscape is poised to drive over USD 1 trillion annually by 2030,...
New Delhi [India], May 2 (ANI): Asia-Pacific region has surged past North America and Europe, occupying 68 spots in the top 100 value...